- Residency and Fellowship Programs
- Advanced Airway Management Fellowship
- Advanced Colon and Rectal Surgical Oncology Fellowship
- Advanced Radiation Oncology Fellowship
- Advanced Therapeutic Endoscopy Fellowship
- Blood Banking/Transfusion Medicine Fellowship
- Body Imaging Fellowship
- Breast Imaging Fellowship
- Breast Surgical Oncology Fellowship
- Cancer Anesthesia Residency/Fellowship
- Cancer Rehabilitation Fellowship
- Cardio-oncology Fellowship
- Complex General Surgical Oncology Fellowship
- Cytopathology Fellowship
- Dermatopathology Fellowship
- Diagnostic Radiology Fellowship
- Gastroenterology, Hepatology & Nutrition Fellowship
- General Internal Medicine Fellowship
- Gynecologic Oncology Fellowship
- Head and Neck Surgical Oncology and Reconstruction Fellowship
- Hematology/Oncology Fellowship Program
- Hematopathology Fellowship
- Hepatopancreatobiliary Surgery Fellowship
- Hospice and Palliative Medicine Fellowships
- Internal Medicine Residency Program
- International Surgical Oncology Fellowship
- Interventional Pulmonology Fellowship
- Interventional Radiology Independent Residency
- Investigational Cancer Therapeutics Fellowship
- Leukemia Fellowship
- Lymphoma/Myeloma Fellowship
- Melanoma Oncology Fellowship
- Micrographic Surgery & Dermatologic Oncology Fellowship
- Microvascular Reconstructive Surgery
- Molecular Genetic Pathology Fellowship
- Musculoskeletal Oncology Fellowship
- Musculoskeletal Radiology Fellowship
- Neuro-Oncology Fellowship
- Neurosurgical Oncology Fellowship
- Oncologic Emergency Medicine Fellowship
- Oncologic Endocrinology Fellowship
- Onco-Hospitalist Fellowship
- Onco-nephrology Fellowship
- Oncologic Audiology Fellowship
- Oncological Neuroradiology
- Ophthalmic Plastic and Reconstructive Surgery Fellowship (ASOPRS /ACGME)
- Advanced Oral Oncology and Maxillofacial Prosthodontics Fellowship
- Pain Medicine Fellowship
- Pediatric Hematology & Oncology Fellowship
- Pediatric Hospice and Palliative Medicine Fellowship
- Pediatric Stem Cell Transplantation Fellowship
- Radiation Oncology Residency
- Regional Anesthesia and Acute Pain Medicine Fellowship
- Selective Breast Pathology Fellowship
- Selective Gastrointestinal & Liver Pathology Fellowship
- Selective Genitourinary Pathology Fellowship
- Selective Gynecologic Pathology Fellowship
- Selective Head & Neck Pathology Fellowship
- Selective Soft Tissue Pathology Fellowship
- Selective Surgical Pathology Fellowship
- Selective Thoracic Pathology Fellowship
- Stem Cell Transplantation and Cellular Therapy
- Surgical Endocrinology Fellowship
- Thoracic Head & Neck Medical Oncology Fellowship
- Thoracic Radiology Fellowship
- Thoracic Surgery Fellowship
- Urinary Tract and Pelvic Reconstruction Fellowship
- Urologic Oncology Fellowship
Leukemia Fellowship
The goals of the Leukemia Fellowship Program are to train competent, qualified, caring and empathic physicians who are mindful of the significance of their role in the diagnosis and management of patients with the acute and chronic leukemias as well as myelodysplastic syndromes and myeloproliferative disorders.
The 1- or optional 2-year program is geared toward a preparation of independent and competent management of patients with all of these disorders. The program is dedicated to training physicians who will effectively work in the current and future health care systems.
The Department of Leukemia at MD Anderson endorses a team approach to patient care, while recognizing that fellows must have opportunities for individual critical decision-making and patient responsibility as defined by the Texas Medical Board.
General Information
General Information
The Leukemia Fellowship Program accepts applications for potential positions August 1, 2023, through October 31, 2023, with the program accepting a limited number of new fellows each year. Initially, a one-year commitment to the Program is required. Fellows in their first year may be considered for an additional year at their request.
The Leukemia Fellowship is non-standard and commences July 1 through June 30 and is recognized by the Texas Medical Board as an approved fellowship program. The program is affiliated with The University of Texas MD Anderson Cancer Center’s Hematology/Oncology Fellowship which is accredited by ACGME.
For general inquires please send email to leuktrain@mdanderson.org.
Achievements
The Program achieves its goals through a combination of inpatient and outpatient clinical experiences. The ACGME core competencies and milestones are achieved through a required set of rotations, a didactic curriculum and elective rotations designed to broaden the base of knowledge. The Fellowship complements the hands on training with an even broader range of conferences that are available through national and international hematology and medical oncology organizations. Fellows are involved in clinical research and are encouraged to develop a research program of his/her own and to compete for national presentations and awards.
The recent achievements of our Program describes an undeniable understanding just how valuable it is to provide in-depth clinical training in the diagnosis and management of leukemia and related malignant disorders (MDS, MPN), and to provide clinical and research training in acute leukemia.
Curriculum
During the first year of fellowship is designed to orient the trainee to the diseases and treatments commonly encountered in leukemia. This intense, hands-on training includes outpatient clinics where the fellow serves as the primary oncologist for the patient, and benefits from close precepting. Fellows are expected to learn about each case from all available resources, including literature and faculty experts. During this time, the fellow also rotates through leukemia inpatient wards to gain focused exposure to specific disease types.
During the optional second year of training, the fellow continues to expand his or her general clinical education through outpatient clinic, inpatient consults and specialty projects. In addition to the clinical responsibilities, fellows begin to focus on a narrow subspecialty, both clinically and in research.
Eligibility Requirements
• Individuals applying for admissions into the Leukemia Fellowship Program must hold either a M.D./D.O. degree or its foreign equivalent along with a valid certificate from the Educational Commission for Foreign Medical Graduates (ECFMG).
• Applicants must have successfully completed and passed the USMLE Step 1 and Step 2 CK exams.
• Applicants must be able to obtain and maintain a Texas Training Permit, required by the Texas State Board of Medical Examiners, and maintain appropriate visa status.
• Individuals who are interested in applying must have completed three (3) years of internal medicine training by the start of the program which begins July 1.
How to Apply
The Leukemia Fellowship Program accepts applications for positions from August 1, 2023 through October 31, 2023.
The deadline for submission of applications for the 2024-2025 Academic Year (July 1, 2024-June 30, 2025) is October 31, 2023.
All application contingencies must be finalized prior to the deadline. Incomplete applications and late inquiries are not accepted.
• To initiate the application process, please submit a current CV to leuktrain@mdanderson.org
• Positions are available on a highly-competitive basis.
• Applications are accepted through the DISCOVER application system.
• The application checklist provides information on all required documents to upload into DISCOVER and/or to request from other entities.
• Interviews will tentatively be conducted upon completion of all application requirements, and, if chosen to move forward in the selection process.
Program Leadership
Guillermo
Garcia-Manero, M.D.
Training Program Director
Tapan
M. Kadia, M.D.
Associate Training Program Director
Hagop M. Kantarjian, M.D.
Department Chair
Meet Our Fellows
Current
Emmanuel Almanza-Huante, M.D.
2023-2024
Universidad Autónoma de Aguascalientes, Aguascalientes, Mexico
Instituto Nacional de Cancerología, Mexico City, Mexico
Alex Bataller, M.D., Ph.D.
2023-2024
University of Barcelona, Spain
Hospital Clinic of Barcelona, Spain
Ian Bouligny, M.D.
2023-2024
Virginia Commonwealth University Massey Cancer Center
Richmond, Virginia
Julie Salman Braish, MBBCh
2023-2024
University of Connecticut
Robert Briski, M.D.
2022-2023
Wayne State University School of Medicine, Detroit, MI, USA
University of Miami, Miami, FL, USA
Georgina Gener-Ricós, M.D.
2022-2023
University of Girona, Girona, Spain
Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain
Akhil Jain, M.D.
2023-2024
Mercy Catholic Medical Center, Darby, PA
Medical Oncology at B.J. Medical College, Ahmedabad, India
Wei Ying JEN, MA (Oxon), BM BCh, M. Med (Internal Medicine), MRCP (UK), FRCPath (Hematology)
2023-2024
National University Cancer Institute, Singapore (NCIS)
University of Oxford, United Kingdom
Patrice Eric Nasnas, M.D.
2022-2023
LAU Gilbert and Rose-Marie Chagoury School of Medicine, Lebanon
Lebanese Hospital Geitawi with the Lebanese University, Beirut, Lebanon
Alumni
Class of 2023
Fellow | Next Assignment | Location
Tareq Abuasab, M.D. | Assistant Professor - Hematology & Oncology | Baylor College of Medicine | Houston, TX
Alexandre Bazinet, M.D. | Assistant Professor - Leukemia | MD Anderson Cancer Center | Houston, TX
Rodrick Babakhanlou, M.D. | Consultant | The Royal Marsden Hospital | London, United Kingdom
Sai Prasad Desikan, M.D. | Clinical Fellow - Nephrology | Ohio State University | Columbus, OH
Faustine Ong, M.D. | Clinical Fellow | Moffitt Cancer Center | Tampa, FL
Jayastu Senapati, M.D. | Assistant Professor - Leukemia | MD Anderson Cancer Center | Houston, TX
Class of 2022
Fellow | Next Assignment | Location
Daniel Rivera, M.D. | UT Health Houston Program (Hematopathology Residency) | Houston, TX
Fadi Haddad, M.D. | MD Anderson - Assistant Professor - Leukemia | Houston, Texas
Kunhwa Kim, M.D. | MD Anderson – DoCM Hematology/Oncology Fellow | Houston, Texas
Sangeetha Venugopal, M.D. | Sylvester Cancer Center, University of Miami (Assistant Professor) | Miami, FL
Class of 2021
Fellow | Next Assignment | Location
Yasmin Alwash, M.D. | Mount Sinai Medical Center | Miami, Florida
Danielle Hammond, M.D. | MD Anderson Cancer Center | Houston, Texas
Shehab Mohamed, M.D. | National Center of Cancer Care and Research | Doha, Qatar
Kiyomi Morita, M.D. Ph.D. | AstraZeneca | Tokyo, Japan
Jorge Ramos-Perez, M.D. | City of Hope Comprehensive Cancer Center | Duarte, CA
Maria Siddiqui, M.D. | Baylor College of Medicine | Houston, Texas
Class of 2020
Fellow | Next Assignment | Location
Hycienth Ahaneku, M.D., Dr.PH. | Beaumont Health System Royal | Oak, Michigan
Ahmad Saleh T Alotaibi, M.D. | King Faisal Specialist Hospital | Riyadh, Saudi Arabia
Veronica Guerra, M.D. | Mount Sinai Medical Center | Miami, Florida
Arrvind Raghunath, MBBS | Texas Tech University Health Sciences Center | Lubbock, Texas
Bachra Samra, M.D. | Presbyterian Healthcare System | Albuquerque, New Mexico
Omar Shahin, MBBCh | King Hussein Cancer Center | Amnan, Jordan
Guillaume Richard-Carpentier, M.D. | Queen's University Kingston | Ontario, Canada
Class of 2019
Fellow | Next Assignment | Location
Iman Abou Dalle, M.D. | American University of Beirut - Lebanon | Beirut, Lebanon
Mansour Alfayez, M.D. | King Fahad Medical City | Riyadh, Saudi Arabia
Yamil Michelen Alvarez, M.D. | Stony Brook University Hospital | Stony Brook, New York
Darwin Roman, M.D. | University of Southern California | Los Angeles, California
Mahran Shoukier, M.D. | MD Anderson Cancer Center - Gen. Internal Med. (Fellow) | Houston, Texas
Mahesh Swaminathan, MBBS | Roswell Park Comprehensive Cancer Center | Buffalo, New York
Eran Tallis, M.D. | Baylor College of Medicine | Houston, Texas
Fevzi Firat Yilnaz, M.D. | MD Anderson Cancer Center - Stem Cell (Fellow) | Houston, Texas
Contact Information
Erich Oley
Program Coordinator, Education
Mary Silverstein
Department Administrator
For additional inquiries, email: LeukTrain@mdanderson.org
All required documents must be sent by postal or express mail to the following addresses:
Document submission requirements will vary.
POSTAL SERVICE
Leukemia Fellowship Program
The University of Texas MD Anderson Cancer Center
Department of Leukemia
ATTN: ERICH OLEY
1515 Holcombe Blvd., Unit 428
Houston, TX 77030
EXPRESS MAIL
Leukemia Fellowship Program
The University of Texas MD Anderson Cancer Center
Department of Leukemia
ATTN: ERICH OLEY
1400 Holcombe Boulevard
FC3.3028
Houston, TX 77030
MD Anderson Cancer Center is committed to encouraging good health and staying true to our mission to end cancer. If you are applying for a GME fellowship or residency program starting on or after July 1, 2016, please be advised that MD Anderson will have instituted a tobacco-free hiring process as part of its efforts to achieve these goals. If you are offered an appointment, you will be subject to a Pre-Employment Drug Screen for tobacco compounds in compliance with applicable state laws. If you do not pass the urine drug screening which includes testing for tobacco compounds, you CANNOT be appointed at MD Anderson. Should you fail to meet this contingency, MD Anderson will withdraw your offer of appointment for the academic year. You may reapply for the following academic year, but there are no guarantees that you will be offered a position as many of our programs are already filled for several years out.
Our Labs
Learn more about our faculty and research taking place in our labs.
Conferences
View conferences available for continuing education credit.